Israeli-headquartered RedHill Biopharma (Nasdaq: RDHL) today revealed its plan to submit a UK marketing authorization application (MAA) for Talicia (low-dose rifabutin-triple therapy) for treatment of ...

Bad breath (medically known as halitosis) is a symptom of gastrointestinal (GI) conditions, such as acid reflux and ulcers.

RedHill Biopharma (RDHL) announced its plan to submit a UK Marketing Authorisation Application for Talicia for treatment of helicobacter pylori ...

Medically reviewed by Marla Anderson, MD Stomach cancer—or gastric cancer—occurs when cells in the lining of the stomach wall ...

in the UK for its Helicobacter pylori (H. pylori) infection treatment, Talicia. According to InvestingPro analysis, the stock appears undervalued despite experiencing significant volatility, with a ...

Researchers conducted a large-scale online survey of clinicians in the Asia-Pacific region to investigate treatment policies for the gastric cancer-causing bacteria Helicobacter pylori.

Helicobacter pylori bacteria is considered to be the ... conducted an online survey of clinicians in the Asia-Pacific region to investigate treatment policies for H. pylori. The findings were ...

Helicobacter pylori bacteria is considered to be the main cause of gastric cancer, with the infection rate particularly high ...